Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000609366 | SCV000712824 | uncertain significance | not specified | 2017-01-28 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The p.Met4534Val va riant in GPR98 has not been previously reported in individuals with hearing loss , but has been identified in 1/8888 African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs761667882). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conserv ation analysis suggest that the p.Met4534Val variant may not impact the protein. Of note, the methionine (Met) at position 4534 is not conserved through species , with 1 mammal (goat) having a valine (Val). In summary, while the clinical sig nificance of the p.Met4534Val variant is uncertain, its presence in other specie s suggests that it is more likely to be benign. |
Labcorp Genetics |
RCV003767453 | SCV004615964 | benign | not provided | 2023-12-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004619351 | SCV005117023 | uncertain significance | Inborn genetic diseases | 2024-06-07 | criteria provided, single submitter | clinical testing | The c.13600A>G (p.M4534V) alteration is located in exon 67 (coding exon 67) of the ADGRV1 gene. This alteration results from a A to G substitution at nucleotide position 13600, causing the methionine (M) at amino acid position 4534 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |